← Every applicant

Biosense Webster, Inc. FDA Approvals

0 new drug approvals and 15 device clearances on file. This applicant is not matched to a listed company.

Newest first

A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.

Product
CARTO™ 3 EP Navigation System V8.4510(k)Feb 20, 2026Cardiovascular
CARTO™ 3 EP Navigation System V9.0 with PIU Plus510(k)Jan 18, 2026Cardiovascular
CARTO™ 3 EP Navigation System V8.1510(k)Aug 22, 2025Cardiovascular
NUVISION™ Ultrasound Catheter; NUVISION™ NAV Ultrasound Catheter510(k)Jun 28, 2024Cardiovascular
SOUNDSTAR™ CRYSTAL Ultrasound Catheter510(k)Jun 12, 2024Cardiovascular
CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00, FG-5400-00U)510(k)Sep 7, 2023Cardiovascular
PENTARAY® NAV ECO High Density Mapping Catheter, DECANAV® Mapping Catheter, Webster® CS Catheter with Auto ID, Webster® CS Catheter with EZ Steer Technology, Webster® CS Catheter with EZ Steer Technology with Auto ID510(k)Jul 10, 2023Cardiovascular
CARTO VIZIGO® 8.5F Bi-Directional Guiding Sheath (D-1385-01-S, D-1385-02-S, D-1385-03-S)510(k)Jul 10, 2023Cardiovascular
OPTRELL™ Mapping Catheter with TRUEref™ Technology510(k)Mar 2, 2023Cardiovascular
CARTO® 3 EP Navigation System with CARTOSOUND™ 4D Version 7.4510(k)Feb 16, 2023Cardiovascular
NUVISION™ NAV Ultrasound Catheter510(k)Feb 16, 2023Cardiovascular
CARTO 3 EP Navigation System with Advanced Focus Mapping (AFM)510(k)Aug 17, 2022Cardiovascular
OPTRELL Mapping Catheter with TRUEref Technology510(k)Mar 18, 2022Cardiovascular
LASSOSTAR NAV Circular Mapping Catheter510(k)Jan 26, 2022Cardiovascular
CARTO 3 EP Navigation System Version 7.2510(k)Oct 29, 2021Cardiovascular

Related datasets